IMPROVEMENT OF THE DISSOLUTION PROFILE OF SIMVASTATIN TABLETS WITH THE ADDITION OF CREMOPHOR-EL USING WET GRANULATION METHOD

Authors

  • FIRMAN GUSTAMAN Pharmacist Professional Education Study Program, STIKes Bakti Tunas Husada, Tasikmalaya, Indonesia
  • KENI IDACAHYATI Pharmacist Professional Education Study Program, STIKes Bakti Tunas Husada, Tasikmalaya, Indonesia
  • WINDA TRISNA WULANDARI Pharmacy Study Program, STIKes Bakti Tunas Husada, Tasikmalaya, Indonesia
  • FAJAR SETIAWAN Pharmacy Study Program, STIKes Bakti Tunas Husada, Tasikmalaya, Indonesia
  • INDRA INDRA Pharmacy Study Program, STIKes Bakti Tunas Husada, Tasikmalaya, Indonesia

DOI:

https://doi.org/10.22159/ijap.2021.v13s4.43869

Keywords:

Simvastatin, Cremophor-EL, Dissolution

Abstract

Objective: Simvastatin is a drug used as a first-line anti-cholesterol in the treatment of dyslipidemia. Low solubility will affect its ability to penetrate the digestive tract membrane and will affect the amount of drug levels in the plasma. The use of Cremophor-EL as a surfactant has been shown to inhibit the action of P-glycoprotein so that it can increase the bioavailability of a drug and can increase the effect of a drug.

Methods: The preparation of simvastatin tablets was carried out using the wet granulation method. The dissolution test used the paddle method, a speed of 50 rpm at a temperature of 37±0.5 ° C with a phosphate buffer pH 7.0 as the dissolution medium.

Results: The results showed that at 30 min the generic simvastatin tablets had 81.52% dissolution and the Simvastatin Tablets with Cremophor-EL were 85.520%.

Conclusion: Simvastatin cremophor-EL tablets are more dissolved than generic simvastatin at 30 min so that cremophor-EL simvastatin tablets have a better dissolution rate than generic simvastatin tablets.

Downloads

Download data is not yet available.

References

Jiang T, Han N, Zhao B, Xie Y, Wang S. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm. 2012;38(10):1230-9. doi: 10.3109/03639045.2011.645830, PMID 22229827.

Murtaza G. Solubility enhancement of simvastatin: a review. Acta Pol Pharm. 2012;69(4):581-90. PMID 22876598.

Khan FM, Ahmad M, Idrees HA. Simvastatin-nicotinamide co-crystals: formation, pharmaceutical characterization and in vivo profile. Drug Des Devel Ther. 2020;14:4303-13. doi: 10.2147/DDDT.S270742, PMID 33116417.

Rao M, Mandage Y, Thanki K, Bhise S. Dissolution improvement of simvastatin by surface solid dispersion technology. Diss Technol. 2010;17(2):27-34. doi: 10.14227/DT170210P27.

Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20. doi: 10.1023/a:1016212804288, PMID 7617530.

Patel R, Patel M. Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. J Dispers Sci Technol. 2008;29(2):193-204. doi: 10.1080/01932690701706946.

Sopyan I, Fudholi A, Muchtaridi M, Sari IP. Co-crystallization: A tool to enhance solubility and dissolution rate of simvastatin. J Young Pharm. 2017;9(2):183-6. doi: 10.5530/jyp.2017.9.36.

Kim KH, Park JB, Choi WJ, Lee HS, Kang CY. Preparation and characterization of simvastatin solid dispersion using aqueous solvent. J Pharm Investig. 2011;4(41):239–47. doi: 10.4333/kps.2011.41.4.239.

Bolourchian N, Mahboobian MM, Dadashzadeh S. The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran J Pharm Res. 2013;12Suppl:11-20. doi: 10.22037/ijpr.2013.1267, PMID 24250667.

Gozali D, Rusdiana T, Gustaman F. Improvement dissolution rate and bioavailability of simvastatin tablet, Maj. Farmasetika. 2019;4Suppl 1:50-9.

Zimper U, Aaltonen J, Krauel Goellner K, Gordon KC, Strachan CJ, Rades T. The influence of milling on the dissolution performance of simvastatin. Pharmaceutics. 2010;2(4):419-31. doi: 10.3390/pharmaceutics2040419, PMID 27721365.

Santl M, Ilic I, Vrecer F, Baumgartner S. A compressibility and compactibility study of real tableting mixtures: the effect of granule particle size. Acta Pharm. 2012;62(3):325-40. doi: 10.2478/v10007-012-0028-8, PMID 23470346.

Kesahatan D. Republik Indonesia. Farmakope Indonesia edisi VI. Jakarta: departemen Kesahatan Republik Indonesia; 2020.

Elkadi S, Elsamaligy S, Al-Suwayeh S, Mahmoud H. The development of self-nanoemulsifying Liquisolid tablets to improve the dissolution of simvastatin. AAPS PharmSciTech. 2017;18(7):2586-97. doi: 10.1208/s12249-017-0743-z, PMID 28236269.

Al-Gousous J, Langguth P. Oral solid dosage form disintegration testing-the forgotten test. J Pharm Sci. 2015;104(9):2664-75. doi: 10.1002/jps.24303, PMID 25546430.

Published

11-12-2021

How to Cite

GUSTAMAN, F., IDACAHYATI, K., WULANDARI, W. T., SETIAWAN, F., & INDRA, I. (2021). IMPROVEMENT OF THE DISSOLUTION PROFILE OF SIMVASTATIN TABLETS WITH THE ADDITION OF CREMOPHOR-EL USING WET GRANULATION METHOD. International Journal of Applied Pharmaceutics, 13(4), 244–246. https://doi.org/10.22159/ijap.2021.v13s4.43869

Issue

Section

Original Article(s)